Medpace (MEDP): Buy, Sell, or Hold Post Q2 Earnings?

Medpace currently trades at $610.21 and has been a dream stock for shareholders. It’s returned 238% since August 2021, more than tripling the S&P 500’s 70.1% gain. The company has also beaten the index over the past six months as its stock price is up 35.1% thanks to its solid quarterly results.